Ireland
--:--IST
Priya Life Science Clinical trial register
Trackers› Clinical trials› Esophageal Cancer
Clinical trial register · France

Esophageal Cancer Trials in France, 2026

Every study on the ClinicalTrials.gov registry that lists a site in France and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 9726 matching records held by the registry are in this view. Synced 17 Nov 2026, 03:21 UTC
9726
Studies in scope
all four open statuses
6052
Recruiting now
open to new participants
1030
Lead sponsors
across recruiting studies
Top sites
Lille 4 Paris 4 Marseille 3 Lyon 3 Villejuif 3
Narrow the registerReset
Recruitment status
Phase
Target enrolment
to

Esophageal Cancer trials in France

11 of 9726 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Sites in France
Start
Recruiting
University Hospital, Bordeaux
Observational
670
Pessac
2026-11-01
Recruiting
PAravertebral CaTheter Versus Epidural Analgesia in Totally Minimally Invasive Esophagectomies
NCT07434739Esophageal Cancer, Esophagectomy, Multimodal Analgesia, Minimally Invasive Surgery
University Hospital, Lille
Not applicable
506
Lille
2026-06-22
Recruiting
Phase 1 Study of PF-08046033 in Advanced Solid Tumors
NCT07519655Non-Small-Cell Lung, Esophageal Cancer, Cutaneous Melanoma
Pfizer
Phase 1
250
Toulouse, Villejuif
2026-04-08
Recruiting
AstraZeneca
Phase 3
2,130
Bordeaux, Caen, Lyon, Marseille, Rennes, Villejuif
2026-02-03
Recruiting
Merck Sharp & Dohme LLC
Phase 1/2
160
Brest, Lille, Paris
2024-09-20
Recruiting
Substudy 06D: Combination Therapies in Second Line (2L) Gastroesophageal Adenocarcinoma (MK-3475-06D/Keymaker-U06)
NCT06445972Gastroesophageal Junction, Gastroesophageal Adenocarcinoma, Esophageal Neoplasms, Esophageal Cancer
Merck Sharp & Dohme LLC
Phase 1/2
210
Brest, Lille, Paris
2024-08-07
Recruiting
GERCOR - Multidisciplinary Oncology Cooperative Group
Not applicable
72
Dijon, Grenoble, Lille, Marseille, Reims, Rouen, Saint-Cloud, Saint-Herblain
2024-06-24
Recruiting
Institute for Clinical and Experimental Medicine
Observational
30
Marseille
2023-10-12
Recruiting
Evaluate BL-B01D1 in Patients With Metastatic or Unresectable Non-Small Cell Lung Cancer (NSCLC) and Other Solid Tumors
NCT05983432Non Small Cell Lung Cancer, Esophageal Cancer, Small Cell Lung Cancer, Nasopharyngeal Cancer
SystImmune Inc.
Phase 1
540
Lyon, Paris, Saint-Herblain, Villejuif
2023-08-08
Recruiting
PROton Versus Photon Therapy for Esophageal Cancer - a Trimodality Strategy
NCT05055648Esophageal Cancer, Radiotherapy, Side Effect, Proton Therapy
University of Aarhus
Phase 3
396
Lyon, Nice, Paris
2022-05-01
Recruiting
Fluorescence Image Guided Foregut Surgery
NCT04734821Esophageal Cancer, Gastric Cancer
IHU Strasbourg
Not applicable
60
Strasbourg
2021-04-01
Rows per page Showing 1–11 of 11
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a French investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 18 November 2026. https://priyalifescience.com/clinical-trials-france/condition/esophageal-cancer

Query this register directly
GET /api/trials?country=in&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in France and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 9,726 studies in total at the last sync on 17 Nov 2026, 03:21 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 11 of those studies listing the condition Esophageal Cancer.

How many Esophageal Cancer trials are recruiting in France?

11 of the 11 studies on this page are recruiting new participants as of the 17 Nov 2026, 03:21 UTC sync. A further 0 have not yet opened recruitment, 0 are active but closed to new participants, and 0 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Esophageal Cancer), 11 studies
PhaseStudiesRecruitingShare
Not applicable3327.3%
Observational2218.2%
Phase 12218.2%
Phase 1/22218.2%
Phase 32218.2%

Most active sponsors

Lead sponsors with the most studies (Esophageal Cancer)
Lead sponsorStudiesRecruiting
Merck Sharp & Dohme LLC22
AstraZeneca11
GERCOR - Multidisciplinary Oncology Cooperative Group11
IHU Strasbourg11
Institute for Clinical and Experimental Medicine11
Pfizer11
SystImmune Inc.11
University Hospital, Bordeaux11
University Hospital, Lille11
University of Aarhus11
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and China registers.